DEANNA NAST: Open Payments
NPI 1881983112 · BATESVILLE, AR. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$489 in 22 payments from 7 companies in 2025. Trend: 2023 $36 · 2024 $95 · 2025 $489
Food & beverage: $489
| Company | Payments | Amount |
|---|---|---|
| E.R. Squibb & Sons, L.L.C. | 6 | $132 |
| Janssen Pharmaceuticals, Inc | 4 | $108 |
| Neurocrine BioSciences, Inc. | 4 | $71 |
| Axsome Therapeutics, Inc. | 2 | $62 |
| ABBVIE INC. | 3 | $52 |
| Otsuka America Pharmaceutical, Inc. | 2 | $38 |
| Alkermes, Inc. | 1 | $25 |
Products named: COBENFY, INGREZZA, Auvelity, SPRAVATO, VRAYLAR, INVEGA SUSTENNA, REXULTI, ARISTADA.
Industry payments across AR — which companies pay providers there.
